SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-007674
Filing Date
2022-05-09
Accepted
2022-05-06 19:00:30
Documents
13
Period of Report
2022-05-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20220504x8k.htm   iXBRL 8-K 37875
2 EX-3.1 aytu-20220504xex3d1.htm EX-3.1 117616
  Complete submission text file 0001558370-22-007674.txt   306124

Data Files

Seq Description Document Type Size
3 EX-101.SCH aytu-20220504.xsd EX-101.SCH 3054
4 EX-101.LAB aytu-20220504_lab.xml EX-101.LAB 16686
5 EX-101.PRE aytu-20220504_pre.xml EX-101.PRE 10625
7 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20220504x8k_htm.xml XML 5006
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 22902805
SIC: 2834 Pharmaceutical Preparations